<DOC>
	<DOC>NCT01466257</DOC>
	<brief_summary>RATIONALE: DNA analysis of tumor tissue may help doctors predict how well patients will respond to treatment. PURPOSE: This research study is studying biomarkers in patients with head and neck cancer.</brief_summary>
	<brief_title>Biomarkers in Patients With Head and Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES: - To determine the mutation rates of HRAS and PIK3CA in patients with head and neck squamous cell carcinoma (HNSCC) who were treated with cisplatin/placebo and cisplatin/cetuximab on protocol ECOG-E5397. - To determine the association between HRAS or PIK3CA mutation status and clinical benefits (i.e., response, progression-free survival, and overall survival) in patients treated with cisplatin/cetuximab compared with those receiving cisplatin/placebo on protocol ECOG-E5397. OUTLINE: DNA is isolated from one unstained slide per patient. The mutations in HRAS and PIK3CA are determined using BEAMING technology.</detailed_description>
	<mesh_term>Carcinoma, Squamous Cell</mesh_term>
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>DISEASE CHARACTERISTICS: Treated on protocol ECOGE5397 PATIENT CHARACTERISTICS: Not specified PRIOR CONCURRENT THERAPY: See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>metastatic squamous neck cancer with occult primary squamous cell carcinoma</keyword>
	<keyword>recurrent metastatic squamous neck cancer with occult primary</keyword>
	<keyword>recurrent squamous cell carcinoma of the hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma of the larynx</keyword>
	<keyword>recurrent squamous cell carcinoma of the lip and oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma of the oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity</keyword>
	<keyword>stage III squamous cell carcinoma of the hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma of the larynx</keyword>
	<keyword>stage III squamous cell carcinoma of the lip and oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma of the oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma of the paranasal sinus and nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma of the hypopharynx</keyword>
	<keyword>stage IVA squamous cell carcinoma of the larynx</keyword>
	<keyword>stage IVA squamous cell carcinoma of the lip and oral cavity</keyword>
	<keyword>stage IVA squamous cell carcinoma of the oropharynx</keyword>
	<keyword>stage IVA squamous cell carcinoma of the paranasal sinus and nasal cavity</keyword>
	<keyword>stage IVB squamous cell carcinoma of the larynx</keyword>
	<keyword>stage IVB squamous cell carcinoma of the lip and oral cavity</keyword>
	<keyword>stage IVB squamous cell carcinoma of the oropharynx</keyword>
	<keyword>stage IVB squamous cell carcinoma of the paranasal sinus and nasal cavity</keyword>
	<keyword>stage IVC squamous cell carcinoma of the larynx</keyword>
	<keyword>stage IVC squamous cell carcinoma of the lip and oral cavity</keyword>
	<keyword>stage IVC squamous cell carcinoma of the oropharynx</keyword>
	<keyword>stage IVC squamous cell carcinoma of the paranasal sinus and nasal cavity</keyword>
	<keyword>untreated metastatic squamous neck cancer with occult primary</keyword>
</DOC>